IoM Report Blames FDA Leadership Crisis For Failure To Improve Drug Safety
Executive Summary
The Institute of Medicine's report on the current state of FDA's drug safety regulation "may not fully reflect a lot of the changes that have been made" at the Center for Drug Evaluation & Research, Deputy Commissioner for Operations Janet Woodcock said Sept. 22
You may also be interested in...
FDA, CDC Leaders Under Trump Urge Fixed Terms For US Health Agency Heads
Former FDA Commissioner Stephen Hahn and former CDC Director Robert Redfield said leaders of their agencies and NIH should be selected outside the election schedule. White House task force reviewing political interference with agency science.
Hahn Urges Fixed Terms For US FDA Leaders
Former commissioner Stephen Hahn and former CDC Director Robert Redfield said leaders of their agencies and NIH should be selected outside the election schedule. White House task force reviewing political interference with agency science.